Smartphone app trial aims to tame side effects for advanced breast cancer treatment
Disease control
Recruiting now
This study is testing a two-drug combination (T-DXd and pertuzumab) as the first treatment for people with advanced HER2-positive breast cancer that has spread. It aims to see how well the treatment works and how it affects quality of life, while using a special smartphone app, a…
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC